Stocks and Investing
Stocks and Investing
Mon, April 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (CDXC) at Strong Buy with Decreased Target to $8 on, Apr 18th, 2022
Raghuram Selvaraju of HC Wainwright & Co., Maintained "ChromaDex Corporation" (CDXC) at Strong Buy with Decreased Target from $12 to $8 on, Apr 18th, 2022.
Raghuram has made no other calls on CDXC in the last 4 months.
There are 2 other peers that have a rating on CDXC. Out of the 2 peers that are also analyzing CDXC, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Jeff Van Sinderen of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $8 on, Thursday, March 10th, 2022
- Sean McGowan of "Roth Capital" Initiated at Strong Buy and Held Target at $7 on, Tuesday, March 8th, 2022
Contributing Sources